| Autor: |
Sun, Kaiyue, Luo, Shudi, Jiang, Yujia, Guo, Jiazheng, Wang, Xi, Cheng, Kexuan, Xu, Changyan, Zhang, Yixiao, Gao, Chen, Lu, Jiansheng, Du, Peng, Yu, Yunzhou, Wang, Rong, Yang, Zhixin, Zhou, Chunyang |
| Předmět: |
|
| Zdroj: |
Archives of Toxicology; Dec2024, Vol. 98 Issue 12, p4187-4195, 9p |
| Abstrakt: |
Botulinum toxin (BoNT) from Clostridium botulinum is the most toxic biotoxin known and is also an important bioterrorism agent. After poisoning, the only effective treatment is injection of antitoxin. However, neutralizing nanoantibodies are safer and more effective, representing a promising therapeutic approach. Therefore, it is important to obtain effective neutralizing nanoantibodies. Hence, the present study aimed to construct a phage antibody library by immunizing a camel and screening specific clones that bind to the L-HN domain of BoNT/F and constructing chimeric heavy-chain antibodies by fusing them with a human Fc fragment. The antibodies' affinity and in vivo neutralizing activities were evaluated. The results showed that 2 µg of F20 antibody could completely neutralize 20 × the median lethal dose (LD50) of BoNT/F in vitro. Injection of 5 mg/kg F20 at 1 h, 2 h, 3 h, and 4 h into mice after BoNT/F challenge resulted in complete survival in vivo. Overall, the antibody might be a candidate for the development of new drugs to treat botulism. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink